The core activity of Phargentis SA is the virtual development of pharmaceuticals, in particular the development of complex dosage forms for generics and innovative SuperGenerics products, as well as the licensing of these products to leading pharmaceutical companies worldwide.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
✓ Offered5
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Development of complex dosage forms for Early Market Entry Generic Drugs and SuperGeneric products, focusing on respiratory diseases and future expansion into oncology.
Licensing of pharmaceutical products
Licensing-out to pharma partners worldwide for market access, including licensing agreements with leading pharmaceutical companies.
Industrialization and project management
Industrialization phase and project management for pharmaceutical development projects, including coordination of manufacturing operations and sales-related operations.
Contract manufacturing management
Management of contract manufacturers for inhalation products in regulated markets, including coordination of sites with FDA and EU inspections.
Inhalation product development
Development of inhalation products with long-standing expertise, including technical, regulatory, patent-related and market-related aspects.
Knowledge
No knowledge articles yet
Once PHARGENTIS SA has claimed this profile, we'll publish editorial articles and case studies here together.